isopropyl myristate has been researched along with tocophersolan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conway, BR; Du, L; Nimmannit, U; Suppasansatorn, P; Wang, Y | 1 |
| Bentley, MV; Casagrande, R; Fonseca, MJ; Georgetti, SR; Verri, WA; Vicentini, FT | 1 |
2 other study(ies) available for isopropyl myristate and tocophersolan
| Article | Year |
|---|---|
Microemulsions as topical delivery vehicles for the anti-melanoma prodrug, temozolomide hexyl ester (TMZA-HE).
Topics: Administration, Cutaneous; Animals; Antineoplastic Agents, Alkylating; Dacarbazine; Detergents; Drug Carriers; Drug Delivery Systems; Emulsions; Esters; In Vitro Techniques; Melanoma; Mice; Mice, Hairless; Myristates; Oleic Acid; Permeability; Pharmaceutical Vehicles; Polyethylene Glycols; Prodrugs; Rats; Skin Absorption; Skin Neoplasms; Solubility; Temozolomide; Vitamin E | 2007 |
Quercetin in lyotropic liquid crystalline formulations: physical, chemical and functional stability.
Topics: Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Dosage Forms; Drug Compounding; Drug Stability; Emulsifying Agents; Free Radical Scavengers; Humidity; Liquid Crystals; Myristates; Polyethylene Glycols; Propylene Glycol; Quercetin; Technology, Pharmaceutical; Temperature; Time Factors; Vitamin E | 2008 |